Future requirement for arterial wall imaging modalities in the evaluation of novel anti-atherosclerotic therapies.
While arterial wall imaging has been used to characterize progression of atherosclerosis, there remain limitations to this approach. A selective overview of emerging modalities to image the artery wall and highlight how they may be used to evaluate emerging anti-atherosclerotic agents. Ongoing developments appear to enable assessment of composition and molecular properties of plaque in addition to quantitation of burden. Non-invasiveness and correlation with clinical outcome remains a challenge. New developments in imaging should enhance the ability to provide early characterization of the potential therapeutic efficacy of experimental agents.